paragraph_index int64 | sec string | p_has_citation int64 | cites string | citeids list | pmid int64 | cited_id string | sentences string | all_sent_cites list | sent_len int64 | sentence_batch_index int64 | sent_has_citation float64 | qc_fail bool | cited_sentence string | cites_in_sentence list | cln_sentence string | is_cap bool | is_alpha bool | ends_wp bool | cit_qc bool | lgtm bool | __index_level_0__ int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | DISCUSSION | 1 | 1 | [
"R1",
"R22",
"R3",
"R22",
"R3",
"R22",
"R12",
"R13",
"R22"
] | 19,793,537 | pmid-10985803|pmid-12396356|pmid-17997603|pmid-15280485|pmid-3232319|pmid-1827578|pmid-3015104|pmid-3685630|pmid-19156578|pmid-18483939|pmid-17296157|pmid-18483939|pmid-17296157|pmid-18483939|pmid-14742263|NA|pmid-18483939 | In an uncomplicated IBV-infected chick, clinical signs such as gasping, coughing, tracheal rales and nasal discharge persist for only 5-to-7 days and disappear within 2 weeks | [
"1",
"22",
"3",
"22",
"3",
"22",
"12",
"13",
"22"
] | 174 | 39,016 | 0 | false | In an uncomplicated IBV-infected chick, clinical signs such as gasping, coughing, tracheal rales and nasal discharge persist for only 5-to-7 days and disappear within 2 weeks | [] | In an uncomplicated IBV-infected chick, clinical signs such as gasping, coughing, tracheal rales and nasal discharge persist for only 5-to-7 days and disappear within 2 weeks | true | true | false | true | false | 6,717 |
1 | DISCUSSION | 1 | 1 | [
"R1",
"R22",
"R3",
"R22",
"R3",
"R22",
"R12",
"R13",
"R22"
] | 19,793,537 | pmid-10985803|pmid-12396356|pmid-17997603|pmid-15280485|pmid-3232319|pmid-1827578|pmid-3015104|pmid-3685630|pmid-19156578|pmid-18483939|pmid-17296157|pmid-18483939|pmid-17296157|pmid-18483939|pmid-14742263|NA|pmid-18483939 | In the recovery stage, unaffected basal cells may be responsible for epithelial hyperplasia after desquamation of the ciliated and goblet cells and reconstruction of the epithelium of the injured respiratory tract to reestablish normal physiological functioning [12, 13, 22]. | [
"1",
"22",
"3",
"22",
"3",
"22",
"12",
"13",
"22"
] | 275 | 39,017 | 0 | false | In the recovery stage, unaffected basal cells may be responsible for epithelial hyperplasia after desquamation of the ciliated and goblet cells and reconstruction of the epithelium of the injured respiratory tract to reestablish normal physiological functioning. | [
"12, 13, 22"
] | In the recovery stage, unaffected basal cells may be responsible for epithelial hyperplasia after desquamation of the ciliated and goblet cells and reconstruction of the epithelium of the injured respiratory tract to reestablish normal physiological functioning. | true | true | true | true | true | 6,717 |
1 | DISCUSSION | 1 | 1 | [
"R1",
"R22",
"R3",
"R22",
"R3",
"R22",
"R12",
"R13",
"R22"
] | 19,793,537 | pmid-10985803|pmid-12396356|pmid-17997603|pmid-15280485|pmid-3232319|pmid-1827578|pmid-3015104|pmid-3685630|pmid-19156578|pmid-18483939|pmid-17296157|pmid-18483939|pmid-17296157|pmid-18483939|pmid-14742263|NA|pmid-18483939 | The insensitivity of basal cells to IBV infection also suggests that coinfection with other viral or bacterial pathogens is required to disrupt basal membrane integrity and cause hemorrhage in IBV-infected tracheas. | [
"1",
"22",
"3",
"22",
"3",
"22",
"12",
"13",
"22"
] | 215 | 39,018 | 0 | false | The insensitivity of basal cells to IBV infection also suggests that coinfection with other viral or bacterial pathogens is required to disrupt basal membrane integrity and cause hemorrhage in IBV-infected tracheas. | [] | The insensitivity of basal cells to IBV infection also suggests that coinfection with other viral or bacterial pathogens is required to disrupt basal membrane integrity and cause hemorrhage in IBV-infected tracheas. | true | true | true | true | true | 6,717 |
2 | DISCUSSION | 1 | 3 | [
"R3",
"R22",
"R21",
"R2",
"R22"
] | 19,793,537 | pmid-10366560|pmid-8116258|pmid-9060710|pmid-9101471|pmid-4565461|pmid-7609057|pmid-15332284|pmid-10366560|pmid-9060710|pmid-17296157|pmid-18483939|pmid-18645889|pmid-2545316|pmid-18483939 | At present, quantification of the virulence of IBV is still a problem [3, 22]. | [
"3",
"22",
"21",
"2",
"22"
] | 78 | 39,019 | 0 | false | At present, quantification of the virulence of IBV is still a problem. | [
"3, 22"
] | At present, quantification of the virulence of IBV is still a problem. | true | true | true | true | true | 6,718 |
2 | DISCUSSION | 1 | 21 | [
"R3",
"R22",
"R21",
"R2",
"R22"
] | 19,793,537 | pmid-10366560|pmid-8116258|pmid-9060710|pmid-9101471|pmid-4565461|pmid-7609057|pmid-15332284|pmid-10366560|pmid-9060710|pmid-17296157|pmid-18483939|pmid-18645889|pmid-2545316|pmid-18483939 | Measuring ciliostasis in TOC is not a sensitive approach for determining the severity of respiratory tract injury caused by IBV infection [21]. | [
"3",
"22",
"21",
"2",
"22"
] | 143 | 39,020 | 1 | false | Measuring ciliostasis in TOC is not a sensitive approach for determining the severity of respiratory tract injury caused by IBV infection. | [
"21"
] | Measuring ciliostasis in TOC is not a sensitive approach for determining the severity of respiratory tract injury caused by IBV infection. | true | true | true | true | true | 6,718 |
2 | DISCUSSION | 1 | 3 | [
"R3",
"R22",
"R21",
"R2",
"R22"
] | 19,793,537 | pmid-10366560|pmid-8116258|pmid-9060710|pmid-9101471|pmid-4565461|pmid-7609057|pmid-15332284|pmid-10366560|pmid-9060710|pmid-17296157|pmid-18483939|pmid-18645889|pmid-2545316|pmid-18483939 | In addition, different species of chicken may also vary in the vulnerability of their respiratory tissue to IBV infection [2, 22]. | [
"3",
"22",
"21",
"2",
"22"
] | 130 | 39,021 | 0 | false | In addition, different species of chicken may also vary in the vulnerability of their respiratory tissue to IBV infection. | [
"2, 22"
] | In addition, different species of chicken may also vary in the vulnerability of their respiratory tissue to IBV infection. | true | true | true | true | true | 6,718 |
2 | DISCUSSION | 1 | 3 | [
"R3",
"R22",
"R21",
"R2",
"R22"
] | 19,793,537 | pmid-10366560|pmid-8116258|pmid-9060710|pmid-9101471|pmid-4565461|pmid-7609057|pmid-15332284|pmid-10366560|pmid-9060710|pmid-17296157|pmid-18483939|pmid-18645889|pmid-2545316|pmid-18483939 | In our ATE system, IBV shows high affinity for ciliated cells and goblet cells. | [
"3",
"22",
"21",
"2",
"22"
] | 79 | 39,022 | 0 | false | In our ATE system, IBV shows high affinity for ciliated cells and goblet cells. | [] | In our ATE system, IBV shows high affinity for ciliated cells and goblet cells. | true | true | true | true | true | 6,718 |
2 | DISCUSSION | 1 | 3 | [
"R3",
"R22",
"R21",
"R2",
"R22"
] | 19,793,537 | pmid-10366560|pmid-8116258|pmid-9060710|pmid-9101471|pmid-4565461|pmid-7609057|pmid-15332284|pmid-10366560|pmid-9060710|pmid-17296157|pmid-18483939|pmid-18645889|pmid-2545316|pmid-18483939 | Cell tropism, viral replication and viral spread can be determined and quantified by immunocytostaining, suggesting that ATE cells could serve as a quantitative platform to determine the pathogenesis of IBV. | [
"3",
"22",
"21",
"2",
"22"
] | 207 | 39,023 | 0 | false | Cell tropism, viral replication and viral spread can be determined and quantified by immunocytostaining, suggesting that ATE cells could serve as a quantitative platform to determine the pathogenesis of IBV. | [] | Cell tropism, viral replication and viral spread can be determined and quantified by immunocytostaining, suggesting that ATE cells could serve as a quantitative platform to determine the pathogenesis of IBV. | true | true | true | true | true | 6,718 |
3 | DISCUSSION | 1 | 18 | [
"R18",
"R32",
"R4"
] | 19,793,537 | pmid-18202946|pmid-17461266|pmid-16603523|pmid-16537586 | It has been shown that sialic acid and HS may help IBV bind to its receptor on the cell membrane of target cells [18, 32]. | [
"18",
"32",
"4"
] | 122 | 39,024 | 0 | false | It has been shown that sialic acid and HS may help IBV bind to its receptor on the cell membrane of target cells. | [
"18, 32"
] | It has been shown that sialic acid and HS may help IBV bind to its receptor on the cell membrane of target cells. | true | true | true | true | true | 6,719 |
3 | DISCUSSION | 1 | 4 | [
"R18",
"R32",
"R4"
] | 19,793,537 | pmid-18202946|pmid-17461266|pmid-16603523|pmid-16537586 | Receptor binding triggers endocytosis and delivers the viral genome into the cytosol through pH-dependent membrane fusion [4]. | [
"18",
"32",
"4"
] | 126 | 39,025 | 1 | false | Receptor binding triggers endocytosis and delivers the viral genome into the cytosol through pH-dependent membrane fusion. | [
"4"
] | Receptor binding triggers endocytosis and delivers the viral genome into the cytosol through pH-dependent membrane fusion. | true | true | true | true | true | 6,719 |
3 | DISCUSSION | 1 | 18 | [
"R18",
"R32",
"R4"
] | 19,793,537 | pmid-18202946|pmid-17461266|pmid-16603523|pmid-16537586 | In this study, we demonstrate that none of the tested GAG interfered with IBV binding to ATE cells. | [
"18",
"32",
"4"
] | 99 | 39,026 | 0 | false | In this study, we demonstrate that none of the tested GAG interfered with IBV binding to ATE cells. | [] | In this study, we demonstrate that none of the tested GAG interfered with IBV binding to ATE cells. | true | true | true | true | true | 6,719 |
3 | DISCUSSION | 1 | 18 | [
"R18",
"R32",
"R4"
] | 19,793,537 | pmid-18202946|pmid-17461266|pmid-16603523|pmid-16537586 | Further investigation is required to test whether this ineffectiveness is due to a lack of the XBBXBX H consensus sequence in the S protein sequences of TW IBV. | [
"18",
"32",
"4"
] | 160 | 39,027 | 0 | false | Further investigation is required to test whether this ineffectiveness is due to a lack of the XBBXBX H consensus sequence in the S protein sequences of TW IBV. | [] | Further investigation is required to test whether this ineffectiveness is due to a lack of the XBBXBX H consensus sequence in the S protein sequences of TW IBV. | true | true | true | true | true | 6,719 |
4 | DISCUSSION | 0 | null | null | 19,793,537 | null | In this study, we established a primary ATE cell culture system for the maintenance and amplification of epithelial cells of the chicken respiratory tract. | null | 155 | 39,028 | 0 | false | null | null | In this study, we established a primary ATE cell culture system for the maintenance and amplification of epithelial cells of the chicken respiratory tract. | true | true | true | true | true | 6,720 |
4 | DISCUSSION | 0 | null | null | 19,793,537 | null | Using these culture conditions, immortalized cell lines could potentially be established by overexpression of oncogenes, telomerase or anti-apoptotic genes. | null | 156 | 39,029 | 0 | false | null | null | Using these culture conditions, immortalized cell lines could potentially be established by overexpression of oncogenes, telomerase or anti-apoptotic genes. | true | true | true | true | true | 6,720 |
4 | DISCUSSION | 0 | null | null | 19,793,537 | null | Both primary cells and respiratory cell lines will provide a new window to reveal viral life cycles, viral persistence, virus-cell interaction and the pathogenesis of avian respiratory viruses. | null | 193 | 39,030 | 0 | false | null | null | Both primary cells and respiratory cell lines will provide a new window to reveal viral life cycles, viral persistence, virus-cell interaction and the pathogenesis of avian respiratory viruses. | true | true | true | true | true | 6,720 |
0 | DISCUSSION | 0 | null | null | 19,509,018 | null | In this report, we provide the evidence that Mstn disruption in Ldlr−/− mice reduces the development of proatherogenic dysipidemia and atherogenesis progression. | null | 161 | 39,031 | 0 | false | null | null | In this report, we provide the evidence that Mstn disruption in Ldlr−/− mice reduces the development of proatherogenic dysipidemia and atherogenesis progression. | true | true | true | true | true | 6,721 |
0 | DISCUSSION | 0 | null | null | 19,509,018 | null | The Mstn−/−/Ldlr−/− mice had lower plasma triglycerides, FFA, and non-HDL cholesterol than controls. | null | 100 | 39,032 | 0 | false | null | null | The Mstn−/−/Ldlr−/− mice had lower plasma triglycerides, FFA, and non-HDL cholesterol than controls. | true | true | true | true | true | 6,721 |
0 | DISCUSSION | 0 | null | null | 19,509,018 | null | Mstn−/−/Ldlr−/− mice also had lower hepatic VLDL secretion rates. | null | 65 | 39,033 | 0 | false | null | null | Mstn−/−/Ldlr−/− mice also had lower hepatic VLDL secretion rates. | true | true | true | true | true | 6,721 |
0 | DISCUSSION | 0 | null | null | 19,509,018 | null | Although we cannot exclude direct actions of myostatin on the blood vessel wall, it is likely that the more favorable plasma lipid profile was the key contributor to reduced atherogenesis progression observed in Mstn−/−/Ldlr−/− mice. | null | 233 | 39,034 | 0 | false | null | null | Although we cannot exclude direct actions of myostatin on the blood vessel wall, it is likely that the more favorable plasma lipid profile was the key contributor to reduced atherogenesis progression observed in Mstn−/−/Ldlr−/− mice. | true | true | true | true | true | 6,721 |
1 | DISCUSSION | 1 | 23 | [
"B23",
"B25",
"B28"
] | 19,509,018 | pmid-10949029|pmid-15680331|pmid-15522994 | Mstn deletion prevented the development of diet-induced insulin resistance in Ldlr−/− mice. | [
"23",
"25",
"28"
] | 91 | 39,035 | 0 | false | Mstn deletion prevented the development of diet-induced insulin resistance in Ldlr−/− mice. | [] | Mstn deletion prevented the development of diet-induced insulin resistance in Ldlr−/− mice. | true | true | true | true | true | 6,722 |
1 | DISCUSSION | 1 | 23 | [
"B23",
"B25",
"B28"
] | 19,509,018 | pmid-10949029|pmid-15680331|pmid-15522994 | Hyperinsulinemic-euglycemic clamp studies revealed that Mstn−/−/Ldlr−/− mice had significantly higher peripheral glucose disposal rates. | [
"23",
"25",
"28"
] | 136 | 39,036 | 0 | false | Hyperinsulinemic-euglycemic clamp studies revealed that Mstn−/−/Ldlr−/− mice had significantly higher peripheral glucose disposal rates. | [] | Hyperinsulinemic-euglycemic clamp studies revealed that Mstn−/−/Ldlr−/− mice had significantly higher peripheral glucose disposal rates. | true | true | true | true | true | 6,722 |
1 | DISCUSSION | 1 | 23 | [
"B23",
"B25",
"B28"
] | 19,509,018 | pmid-10949029|pmid-15680331|pmid-15522994 | Furthermore, decreased circulating insulin as well as decreased glucose and adipose-derived FFA influx to the liver of the double-knockout mice may contribute to the protection against hepatic lipogenesis and hepatic insulin resistance (23,25,28). | [
"23",
"25",
"28"
] | 247 | 39,037 | 0 | false | Furthermore, decreased circulating insulin as well as decreased glucose and adipose-derived FFA influx to the liver of the double-knockout mice may contribute to the protection against hepatic lipogenesis and hepatic insulin resistance. | [
"23,25,28"
] | Furthermore, decreased circulating insulin as well as decreased glucose and adipose-derived FFA influx to the liver of the double-knockout mice may contribute to the protection against hepatic lipogenesis and hepatic insulin resistance. | true | true | true | true | true | 6,722 |
2 | DISCUSSION | 1 | 31 | [
"B31",
"B32",
"B11",
"B33",
"B11",
"B11"
] | 19,509,018 | pmid-18203713|pmid-17030820|pmid-18249175|pmid-11175789|pmid-18249175|pmid-18249175 | The mechanisms by which Mstn deletion improves insulin sensitivity are not fully understood. | [
"31",
"32",
"11",
"33",
"11",
"11"
] | 92 | 39,038 | 0 | false | The mechanisms by which Mstn deletion improves insulin sensitivity are not fully understood. | [] | The mechanisms by which Mstn deletion improves insulin sensitivity are not fully understood. | true | true | true | true | true | 6,723 |
2 | DISCUSSION | 1 | 31 | [
"B31",
"B32",
"B11",
"B33",
"B11",
"B11"
] | 19,509,018 | pmid-18203713|pmid-17030820|pmid-18249175|pmid-11175789|pmid-18249175|pmid-18249175 | Mstn−/−/Ldlr−/− mice remained remarkably lean and resisted fat accumulation even when fed HFD for 12 weeks. | [
"31",
"32",
"11",
"33",
"11",
"11"
] | 107 | 39,039 | 0 | false | Mstn−/−/Ldlr−/− mice remained remarkably lean and resisted fat accumulation even when fed HFD for 12 weeks. | [] | Mstn−/−/Ldlr−/− mice remained remarkably lean and resisted fat accumulation even when fed HFD for 12 weeks. | true | true | true | true | true | 6,723 |
2 | DISCUSSION | 1 | 31 | [
"B31",
"B32",
"B11",
"B33",
"B11",
"B11"
] | 19,509,018 | pmid-18203713|pmid-17030820|pmid-18249175|pmid-11175789|pmid-18249175|pmid-18249175 | Myostatin may exert complex effects on adipogenic differentiation (31,32). | [
"31",
"32",
"11",
"33",
"11",
"11"
] | 74 | 39,040 | 0 | false | Myostatin may exert complex effects on adipogenic differentiation. | [
"31,32"
] | Myostatin may exert complex effects on adipogenic differentiation. | true | true | true | true | true | 6,723 |
2 | DISCUSSION | 1 | 11 | [
"B31",
"B32",
"B11",
"B33",
"B11",
"B11"
] | 19,509,018 | pmid-18203713|pmid-17030820|pmid-18249175|pmid-11175789|pmid-18249175|pmid-18249175 | In addition, it is possible that acquisition of hypermuscularity by itself could lead to leanness (11). | [
"31",
"32",
"11",
"33",
"11",
"11"
] | 103 | 39,041 | 1 | false | In addition, it is possible that acquisition of hypermuscularity by itself could lead to leanness. | [
"11"
] | In addition, it is possible that acquisition of hypermuscularity by itself could lead to leanness. | true | true | true | true | true | 6,723 |
2 | DISCUSSION | 1 | 11 | [
"B31",
"B32",
"B11",
"B33",
"B11",
"B11"
] | 19,509,018 | pmid-18203713|pmid-17030820|pmid-18249175|pmid-11175789|pmid-18249175|pmid-18249175 | Indeed, mice with increased muscle oxidation, such as those overexpressing IGF-1 (33) or Akt-1 (11) in skeletal muscles, have little fat deposition. | [
"31",
"32",
"11",
"33",
"11",
"11"
] | 148 | 39,042 | 1 | false | Indeed, mice with increased muscle oxidation, such as those overexpressing IGF-1 or Akt-1 in skeletal muscles, have little fat deposition. | [
"33",
"11"
] | Indeed, mice with increased muscle oxidation, such as those overexpressing IGF-1 or Akt-1 in skeletal muscles, have little fat deposition. | true | true | true | true | true | 6,723 |
2 | DISCUSSION | 1 | 11 | [
"B31",
"B32",
"B11",
"B33",
"B11",
"B11"
] | 19,509,018 | pmid-18203713|pmid-17030820|pmid-18249175|pmid-11175789|pmid-18249175|pmid-18249175 | In our myostatin-deficient model, the marked hypertrophy of glycolytic skeletal muscle was associated with increased glucose uptake, lower blood glucose levels, and consequently lower circulating levels of insulin (11). | [
"31",
"32",
"11",
"33",
"11",
"11"
] | 219 | 39,043 | 1 | false | In our myostatin-deficient model, the marked hypertrophy of glycolytic skeletal muscle was associated with increased glucose uptake, lower blood glucose levels, and consequently lower circulating levels of insulin. | [
"11"
] | In our myostatin-deficient model, the marked hypertrophy of glycolytic skeletal muscle was associated with increased glucose uptake, lower blood glucose levels, and consequently lower circulating levels of insulin. | true | true | true | true | true | 6,723 |
3 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B34",
"B11",
"B35"
] | 19,509,018 | pmid-15680331|pmid-18349115|pmid-2407476|pmid-18249175|pmid-12920182 | Increased hepatic fatty acid β-oxidation (FAO) and mitochondrial biogenesis with Mstn disruption may prevent the development of hepatic steatosis that was observed in Mstn+/+/Ldlr−/− controls (25,26). | [
"25",
"26",
"34",
"11",
"35"
] | 200 | 39,044 | 0 | false | Increased hepatic fatty acid β-oxidation (FAO) and mitochondrial biogenesis with Mstn disruption may prevent the development of hepatic steatosis that was observed in Mstn+/+/Ldlr−/− controls. | [
"25,26"
] | Increased hepatic fatty acid β-oxidation (FAO) and mitochondrial biogenesis with Mstn disruption may prevent the development of hepatic steatosis that was observed in Mstn+/+/Ldlr−/− controls. | true | true | true | true | true | 6,724 |
3 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B34",
"B11",
"B35"
] | 19,509,018 | pmid-15680331|pmid-18349115|pmid-2407476|pmid-18249175|pmid-12920182 | Consistent with the higher FAO rates, Mstn−/−/Ldlr−/− mice had higher ketone body production than controls. | [
"25",
"26",
"34",
"11",
"35"
] | 107 | 39,045 | 0 | false | Consistent with the higher FAO rates, Mstn−/−/Ldlr−/− mice had higher ketone body production than controls. | [] | Consistent with the higher FAO rates, Mstn−/−/Ldlr−/− mice had higher ketone body production than controls. | true | true | true | true | true | 6,724 |
3 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B34",
"B11",
"B35"
] | 19,509,018 | pmid-15680331|pmid-18349115|pmid-2407476|pmid-18249175|pmid-12920182 | Improved insulin sensitivity might be expected to suppress FAO and lower ketone body production. | [
"25",
"26",
"34",
"11",
"35"
] | 96 | 39,046 | 0 | false | Improved insulin sensitivity might be expected to suppress FAO and lower ketone body production. | [] | Improved insulin sensitivity might be expected to suppress FAO and lower ketone body production. | true | true | true | true | true | 6,724 |
3 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B34",
"B11",
"B35"
] | 19,509,018 | pmid-15680331|pmid-18349115|pmid-2407476|pmid-18249175|pmid-12920182 | However, insulin only effectively suppresses FAO in tissues, primarily muscle and fat, where glucose uptake is tightly regulated by insulin. | [
"25",
"26",
"34",
"11",
"35"
] | 140 | 39,047 | 0 | false | However, insulin only effectively suppresses FAO in tissues, primarily muscle and fat, where glucose uptake is tightly regulated by insulin. | [] | However, insulin only effectively suppresses FAO in tissues, primarily muscle and fat, where glucose uptake is tightly regulated by insulin. | true | true | true | true | true | 6,724 |
3 | DISCUSSION | 1 | 34 | [
"B25",
"B26",
"B34",
"B11",
"B35"
] | 19,509,018 | pmid-15680331|pmid-18349115|pmid-2407476|pmid-18249175|pmid-12920182 | Because hepatic glucose uptake is not regulated by insulin (34), improved insulin sensitivity in the Mstn−/−/ Ldlr−/− mice does not pose limitation on liver FAO as it does in the skeletal muscle. | [
"25",
"26",
"34",
"11",
"35"
] | 195 | 39,048 | 1 | false | Because hepatic glucose uptake is not regulated by insulin, improved insulin sensitivity in the Mstn−/−/ Ldlr−/− mice does not pose limitation on liver FAO as it does in the skeletal muscle. | [
"34"
] | Because hepatic glucose uptake is not regulated by insulin, improved insulin sensitivity in the Mstn−/−/ Ldlr−/− mice does not pose limitation on liver FAO as it does in the skeletal muscle. | true | true | true | true | true | 6,724 |
3 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B34",
"B11",
"B35"
] | 19,509,018 | pmid-15680331|pmid-18349115|pmid-2407476|pmid-18249175|pmid-12920182 | This phenomenon has also been observed by others (11,35). | [
"25",
"26",
"34",
"11",
"35"
] | 57 | 39,049 | 0 | false | This phenomenon has also been observed by others. | [
"11,35"
] | This phenomenon has also been observed by others. | true | true | true | true | true | 6,724 |
3 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B34",
"B11",
"B35"
] | 19,509,018 | pmid-15680331|pmid-18349115|pmid-2407476|pmid-18249175|pmid-12920182 | Our data suggest that the increased ketone body production in the double-knockout mice may be a result of physiological adaptation to limited adipose tissue storage for dietary fats from HFD. | [
"25",
"26",
"34",
"11",
"35"
] | 191 | 39,050 | 0 | false | Our data suggest that the increased ketone body production in the double-knockout mice may be a result of physiological adaptation to limited adipose tissue storage for dietary fats from HFD. | [] | Our data suggest that the increased ketone body production in the double-knockout mice may be a result of physiological adaptation to limited adipose tissue storage for dietary fats from HFD. | true | true | true | true | true | 6,724 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B36",
"B37",
"B38"
] | 19,509,018 | pmid-19295913|pmid-17347387|pmid-18948104|pmid-18718903 | Myostatin may also indirectly affect cardiometabolic risk by its effects on myokine secretion by the skeletal muscle. | [
"10",
"36",
"37",
"38"
] | 117 | 39,051 | 0 | false | Myostatin may also indirectly affect cardiometabolic risk by its effects on myokine secretion by the skeletal muscle. | [] | Myostatin may also indirectly affect cardiometabolic risk by its effects on myokine secretion by the skeletal muscle. | true | true | true | true | true | 6,725 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B36",
"B37",
"B38"
] | 19,509,018 | pmid-19295913|pmid-17347387|pmid-18948104|pmid-18718903 | Similar to systemic loss of Mstn, inhibition of myostatin signaling exclusively in the skeletal muscle was sufficient to resist diet-induced obesity and insulin resistance (10). | [
"10",
"36",
"37",
"38"
] | 177 | 39,052 | 1 | false | Similar to systemic loss of Mstn, inhibition of myostatin signaling exclusively in the skeletal muscle was sufficient to resist diet-induced obesity and insulin resistance. | [
"10"
] | Similar to systemic loss of Mstn, inhibition of myostatin signaling exclusively in the skeletal muscle was sufficient to resist diet-induced obesity and insulin resistance. | true | true | true | true | true | 6,725 |
4 | DISCUSSION | 1 | 36 | [
"B10",
"B36",
"B37",
"B38"
] | 19,509,018 | pmid-19295913|pmid-17347387|pmid-18948104|pmid-18718903 | Myokines, such as interleukin-6, can alter metabolic states (36). | [
"10",
"36",
"37",
"38"
] | 65 | 39,053 | 1 | false | Myokines, such as interleukin-6, can alter metabolic states. | [
"36"
] | Myokines, such as interleukin-6, can alter metabolic states. | true | true | true | true | true | 6,725 |
4 | DISCUSSION | 1 | 10 | [
"B10",
"B36",
"B37",
"B38"
] | 19,509,018 | pmid-19295913|pmid-17347387|pmid-18948104|pmid-18718903 | Other myokines, such as fibroblast growth factor-21 (Fgf-21) and follistatin like-1 (Fstl-1), may also have salutary effects on fat accumulation and insulin sensitivity (37,38). | [
"10",
"36",
"37",
"38"
] | 177 | 39,054 | 0 | false | Other myokines, such as fibroblast growth factor-21 (Fgf-21) and follistatin like-1 (Fstl-1), may also have salutary effects on fat accumulation and insulin sensitivity. | [
"37,38"
] | Other myokines, such as fibroblast growth factor-21 and follistatin like-1, may also have salutary effects on fat accumulation and insulin sensitivity. | true | true | true | true | true | 6,725 |
5 | DISCUSSION | 1 | 39 | [
"B39"
] | 19,509,018 | NA | In summary, we have demonstrated here that Mstn deletion has beneficial cardiometabolic effects in an animal model of atherosclerosis. | [
"39"
] | 134 | 39,055 | 0 | false | In summary, we have demonstrated here that Mstn deletion has beneficial cardiometabolic effects in an animal model of atherosclerosis. | [] | In summary, we have demonstrated here that Mstn deletion has beneficial cardiometabolic effects in an animal model of atherosclerosis. | true | true | true | true | true | 6,726 |
5 | DISCUSSION | 1 | 39 | [
"B39"
] | 19,509,018 | NA | Mstn−/−/Ldlr−/− mice are partially protected against not only fat accumulation and insulin resistance but also the development of proatherogenic dyslipidemia and atherosclerosis. | [
"39"
] | 178 | 39,056 | 0 | false | Mstn−/−/Ldlr−/− mice are partially protected against not only fat accumulation and insulin resistance but also the development of proatherogenic dyslipidemia and atherosclerosis. | [] | Mstn−/−/Ldlr−/− mice are partially protected against not only fat accumulation and insulin resistance but also the development of proatherogenic dyslipidemia and atherosclerosis. | true | true | true | true | true | 6,726 |
5 | DISCUSSION | 1 | 39 | [
"B39"
] | 19,509,018 | NA | These proof-of-concept studies raise the possibility that myostatin inhibitors may be useful agents for the prevention or treatment of atherosclerosis. | [
"39"
] | 151 | 39,057 | 0 | false | These proof-of-concept studies raise the possibility that myostatin inhibitors may be useful agents for the prevention or treatment of atherosclerosis. | [] | These proof-of-concept studies raise the possibility that myostatin inhibitors may be useful agents for the prevention or treatment of atherosclerosis. | true | true | true | true | true | 6,726 |
5 | DISCUSSION | 1 | 39 | [
"B39"
] | 19,509,018 | NA | Importantly, administration of myostatin inhibitors to humans have demonstrated specificity, safety, and effectiveness in increasing muscle mass and decreasing fat mass (39). | [
"39"
] | 174 | 39,058 | 1 | false | Importantly, administration of myostatin inhibitors to humans have demonstrated specificity, safety, and effectiveness in increasing muscle mass and decreasing fat mass. | [
"39"
] | Importantly, administration of myostatin inhibitors to humans have demonstrated specificity, safety, and effectiveness in increasing muscle mass and decreasing fat mass. | true | true | true | true | true | 6,726 |
5 | DISCUSSION | 1 | 39 | [
"B39"
] | 19,509,018 | NA | To the extent that loss of skeletal muscle mass, adiposity, and atherogenesis occur contemporaneously during aging and in many chronic illnesses, new classes of promyogenic drugs, such as myostatin inhibitors, that increase skeletal muscle mass and retard fat accumulation are particularly attractive against these cardi... | [
"39"
] | 341 | 39,059 | 0 | false | To the extent that loss of skeletal muscle mass, adiposity, and atherogenesis occur contemporaneously during aging and in many chronic illnesses, new classes of promyogenic drugs, such as myostatin inhibitors, that increase skeletal muscle mass and retard fat accumulation are particularly attractive against these cardi... | [] | To the extent that loss of skeletal muscle mass, adiposity, and atherogenesis occur contemporaneously during aging and in many chronic illnesses, new classes of promyogenic drugs, such as myostatin inhibitors, that increase skeletal muscle mass and retard fat accumulation are particularly attractive against these cardi... | true | true | true | true | true | 6,726 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | Urinary incontinence (UI) is common in females. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10"
] | 47 | 39,060 | 0 | false | Urinary incontinence (UI) is common in females. | [] | Urinary incontinence (UI) is common in females. | true | true | true | true | true | 6,727 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | The incidence of female UI is 14-41% [1], and the incidence increases with aging [2,3]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10"
] | 87 | 39,061 | 1 | false | The incidence of female UI is 14-41%, and the incidence increases with aging. | [
"1",
"2,3"
] | The incidence of female UI is 14-41%, and the incidence increases with aging. | true | true | true | true | true | 6,727 |
0 | INTRODUCTION | 1 | 4 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | The tension-free vaginal tape (TVT) procedure, which was first described in 1996 by Ulmsten and Petros, is a modified suburethral sling procedure for treating female stress urinary incontinence (SUI) based on the integral theory [4]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10"
] | 233 | 39,062 | 1 | false | The tension-free vaginal tape (TVT) procedure, which was first described in 1996 by Ulmsten and Petros, is a modified suburethral sling procedure for treating female stress urinary incontinence (SUI) based on the integral theory. | [
"4"
] | The tension-free vaginal tape (TVT) procedure, which was first described in 1996 by Ulmsten and Petros, is a modified suburethral sling procedure for treating female stress urinary incontinence (SUI) based on the integral theory. | true | true | true | true | true | 6,727 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | The TVT procedure provides high short- and intermediate-term success rates [5-7]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10"
] | 81 | 39,063 | 0 | false | The TVT procedure provides high short- and intermediate-term success rates. | [
"5-7"
] | The TVT procedure provides high short- and intermediate-term success rates. | true | true | true | true | true | 6,727 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | A few studies showed that the cure rate of the TVT procedure is 76.9-80% after long-term follow up [8-10]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10"
] | 106 | 39,064 | 0 | false | A few studies showed that the cure rate of the TVT procedure is 76.9-80% after long-term follow up. | [
"8-10"
] | A few studies showed that the cure rate of the TVT procedure is 76.9-80% after long-term follow up. | true | true | true | true | true | 6,727 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | However, long-term follow-up data on the TVT procedure are currently lacking in Korea. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10"
] | 86 | 39,065 | 0 | false | However, long-term follow-up data on the TVT procedure are currently lacking in Korea. | [] | However, long-term follow-up data on the TVT procedure are currently lacking in Korea. | true | true | true | true | true | 6,727 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | Therefore, we evaluated the long-term results of the TVT procedure for the treatment of female UI with 6-year follow-up data. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10"
] | 125 | 39,066 | 0 | false | Therefore, we evaluated the long-term results of the TVT procedure for the treatment of female UI with 6-year follow-up data. | [] | Therefore, we evaluated the long-term results of the TVT procedure for the treatment of female UI with 6-year follow-up data. | true | true | true | true | true | 6,727 |
0 | DISCUSSION | 1 | 17 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | SUI is known to occur when the bladder neck and posterior urethra escape the normal anatomical position [17]. | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 109 | 39,067 | 1 | false | SUI is known to occur when the bladder neck and posterior urethra escape the normal anatomical position. | [
"17"
] | SUI is known to occur when the bladder neck and posterior urethra escape the normal anatomical position. | true | true | true | true | true | 6,728 |
0 | DISCUSSION | 1 | 17 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | During a Valsalva maneuver, the pressure of the bladder neck and posterior urethra is lower than intravesical pressure, which leads to incontinence [17]. | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 153 | 39,068 | 1 | false | During a Valsalva maneuver, the pressure of the bladder neck and posterior urethra is lower than intravesical pressure, which leads to incontinence. | [
"17"
] | During a Valsalva maneuver, the pressure of the bladder neck and posterior urethra is lower than intravesical pressure, which leads to incontinence. | true | true | true | true | true | 6,728 |
0 | DISCUSSION | 1 | 17 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | The short-term results of TVT have shown cure rates between 80% and 100% [5-7]. | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 79 | 39,069 | 0 | false | The short-term results of TVT have shown cure rates between 80% and 100%. | [
"5-7"
] | The short-term results of TVT have shown cure rates between 80% and 100%. | true | true | true | true | true | 6,728 |
0 | DISCUSSION | 1 | 17 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | Long-term cure rates are reported to be from 71% to 86% [8-10]. | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 63 | 39,070 | 0 | false | Long-term cure rates are reported to be from 71% to 86%. | [
"8-10"
] | Long-term cure rates are reported to be from 71% to 86%. | true | true | true | true | true | 6,728 |
0 | DISCUSSION | 1 | 18 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | Nilsson et al performed 7 years of long-term follow-up of 80 patients in 2004 and reported an 81.3% cure rate [18]. | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 115 | 39,071 | 1 | false | Nilsson et al performed 7 years of long-term follow-up of 80 patients in 2004 and reported an 81.3% cure rate. | [
"18"
] | Nilsson et al performed 7 years of long-term follow-up of 80 patients in 2004 and reported an 81.3% cure rate. | true | true | true | true | true | 6,728 |
0 | DISCUSSION | 1 | 17 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | In our study, the long-term cure rate was 83.0% (117/141), and this result is almost the same as the results of previous studies. | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 129 | 39,072 | 0 | false | In our study, the long-term cure rate was 83.0%, and this result is almost the same as the results of previous studies. | [
"117/141"
] | In our study, the long-term cure rate was 83.0%, and this result is almost the same as the results of previous studies. | true | true | true | true | true | 6,728 |
0 | DISCUSSION | 1 | 17 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | Razapour and Ulmsten performed TVT on 80 patients with mixed incontinence accompanied by urgency UI and reported an 85% cure rate, a 4% rate of improvement, and an 11% treatment failure rate within a mean follow-up period of 4 years (range, 3-5 years) | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 251 | 39,073 | 0 | false | Razapour and Ulmsten performed TVT on 80 patients with mixed incontinence accompanied by urgency UI and reported an 85% cure rate, a 4% rate of improvement, and an 11% treatment failure rate within a mean follow-up period of 4 years | [
"range, 3-5 years"
] | Razapour and Ulmsten performed TVT on 80 patients with mixed incontinence accompanied by urgency UI and reported an 85% cure rate, a 4% rate of improvement, and an 11% treatment failure rate within a mean follow-up period of 4 years | true | true | false | true | false | 6,728 |
0 | DISCUSSION | 1 | 17 | [
"B17",
"B17",
"B5",
"B7",
"B8",
"B10",
"B18",
"B19"
] | 20,577,608 | pmid-9426746|pmid-2898402|pmid-7427654|pmid-7618052|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-943076|pmid-943076|pmid-19579203|pmid-11305550|pmid-11450979|pmid-17593097|pmid-15572486|pmid-11450974 | In our study, the cure rate of patients with MUI at 1 year postoperatively was 89.8%, and the cure rate at 6 years postoperatively was 79.4%. | [
"17",
"17",
"5",
"7",
"8",
"10",
"18",
"19"
] | 141 | 39,074 | 0 | false | In our study, the cure rate of patients with MUI at 1 year postoperatively was 89.8%, and the cure rate at 6 years postoperatively was 79.4%. | [] | In our study, the cure rate of patients with MUI at 1 year postoperatively was 89.8%, and the cure rate at 6 years postoperatively was 79.4%. | true | true | true | true | true | 6,728 |
1 | DISCUSSION | 1 | 20 | [
"B20",
"B21",
"B22",
"B22"
] | 20,577,608 | pmid-12270565|pmid-12691935|pmid-15994615|pmid-15994615 | In the MUI group, the cure rate of urgency incontinence was decreased from 81.9% at 1 year postoperatively to 58.8% at 6 years postoperatively. | [
"20",
"21",
"22",
"22"
] | 143 | 39,075 | 0 | false | In the MUI group, the cure rate of urgency incontinence was decreased from 81.9% at 1 year postoperatively to 58.8% at 6 years postoperatively. | [] | In the MUI group, the cure rate of urgency incontinence was decreased from 81.9% at 1 year postoperatively to 58.8% at 6 years postoperatively. | true | true | true | true | true | 6,729 |
1 | DISCUSSION | 1 | 20 | [
"B20",
"B21",
"B22",
"B22"
] | 20,577,608 | pmid-12270565|pmid-12691935|pmid-15994615|pmid-15994615 | Previous studies reported that the cure rate of urgency UI in MUI patients was 69-85% with short-term follow-up | [
"20",
"21",
"22",
"22"
] | 111 | 39,076 | 0 | false | Previous studies reported that the cure rate of urgency UI in MUI patients was 69-85% with short-term follow-up | [] | Previous studies reported that the cure rate of urgency UI in MUI patients was 69-85% with short-term follow-up | true | true | false | true | false | 6,729 |
1 | DISCUSSION | 1 | 22 | [
"B20",
"B21",
"B22",
"B22"
] | 20,577,608 | pmid-12270565|pmid-12691935|pmid-15994615|pmid-15994615 | Holmgren et al reported that the cure rate of urgency UI at 3 years postoperatively was 60% and that at 6 to 8 years was 30% [22]. | [
"20",
"21",
"22",
"22"
] | 130 | 39,077 | 1 | false | Holmgren et al reported that the cure rate of urgency UI at 3 years postoperatively was 60% and that at 6 to 8 years was 30%. | [
"22"
] | Holmgren et al reported that the cure rate of urgency UI at 3 years postoperatively was 60% and that at 6 to 8 years was 30%. | true | true | true | true | true | 6,729 |
1 | DISCUSSION | 1 | 22 | [
"B20",
"B21",
"B22",
"B22"
] | 20,577,608 | pmid-12270565|pmid-12691935|pmid-15994615|pmid-15994615 | This might be due to an aging effect or atrophy of the bladder epithelium, which could be associated with the increased use of local estrogens or with neurological disorders [22]. | [
"20",
"21",
"22",
"22"
] | 179 | 39,078 | 1 | false | This might be due to an aging effect or atrophy of the bladder epithelium, which could be associated with the increased use of local estrogens or with neurological disorders. | [
"22"
] | This might be due to an aging effect or atrophy of the bladder epithelium, which could be associated with the increased use of local estrogens or with neurological disorders. | true | true | true | true | true | 6,729 |
2 | DISCUSSION | 1 | 23 | [
"B23",
"B24",
"B25",
"B26",
"B27"
] | 20,577,608 | NA|pmid-3822288|pmid-2392816|NA|pmid-11294532 | There is still controversy about the difference between success rates of TVT procedures according to the VLPP. | [
"23",
"24",
"25",
"26",
"27"
] | 110 | 39,079 | 0 | false | There is still controversy about the difference between success rates of TVT procedures according to the VLPP. | [] | There is still controversy about the difference between success rates of TVT procedures according to the VLPP. | true | true | true | true | true | 6,730 |
2 | DISCUSSION | 1 | 23 | [
"B23",
"B24",
"B25",
"B26",
"B27"
] | 20,577,608 | NA|pmid-3822288|pmid-2392816|NA|pmid-11294532 | In 2001, Kim and Lee reported that the success rate of patients with a VLPP of less than 60 cmH2O was low | [
"23",
"24",
"25",
"26",
"27"
] | 105 | 39,080 | 0 | false | In 2001, Kim and Lee reported that the success rate of patients with a VLPP of less than 60 cmH2O was low | [] | In 2001, Kim and Lee reported that the success rate of patients with a VLPP of less than 60 cmH2O was low | true | true | false | true | false | 6,730 |
2 | DISCUSSION | 1 | 26 | [
"B23",
"B24",
"B25",
"B26",
"B27"
] | 20,577,608 | NA|pmid-3822288|pmid-2392816|NA|pmid-11294532 | In addition, Sand et al and Koonings et al reported that when the VLPP was lower than 60 cmH2O, the failure rate of the Burch operation procedure was 50% [24,25], and Song et al reported that TVT in patients with a low VLPP should be considered cautiously [26]. | [
"23",
"24",
"25",
"26",
"27"
] | 261 | 39,081 | 1 | false | In addition, Sand et al and Koonings et al reported that when the VLPP was lower than 60 cmH2O, the failure rate of the Burch operation procedure was 50%, and Song et al reported that TVT in patients with a low VLPP should be considered cautiously. | [
"24,25",
"26"
] | In addition, Sand et al and Koonings et al reported that when the VLPP was lower than 60 cmH2O, the failure rate of the Burch operation procedure was 50%, and Song et al reported that TVT in patients with a low VLPP should be considered cautiously. | true | true | true | true | true | 6,730 |
2 | DISCUSSION | 1 | 27 | [
"B23",
"B24",
"B25",
"B26",
"B27"
] | 20,577,608 | NA|pmid-3822288|pmid-2392816|NA|pmid-11294532 | Conversely, Hsieh et al reported that in women with a VLPP of less than 60 cmH2O, the success rate showed a high percentage of 91.7%, suggesting that VLPP had no correlation with the success rate [27]. | [
"23",
"24",
"25",
"26",
"27"
] | 201 | 39,082 | 1 | false | Conversely, Hsieh et al reported that in women with a VLPP of less than 60 cmH2O, the success rate showed a high percentage of 91.7%, suggesting that VLPP had no correlation with the success rate. | [
"27"
] | Conversely, Hsieh et al reported that in women with a VLPP of less than 60 cmH2O, the success rate showed a high percentage of 91.7%, suggesting that VLPP had no correlation with the success rate. | true | true | true | true | true | 6,730 |
2 | DISCUSSION | 1 | 23 | [
"B23",
"B24",
"B25",
"B26",
"B27"
] | 20,577,608 | NA|pmid-3822288|pmid-2392816|NA|pmid-11294532 | In our study, we divided the patients into two groups, one with a VLPP of lower than 60 cmH2O and the other with a VLPP of higher than 60 cmH2O, and the success rates did not differ significantly between the groups (81.1% versus 86.7%; p=0.59). | [
"23",
"24",
"25",
"26",
"27"
] | 244 | 39,083 | 0 | false | In our study, we divided the patients into two groups, one with a VLPP of lower than 60 cmH2O and the other with a VLPP of higher than 60 cmH2O, and the success rates did not differ significantly between the groups (81.1% versus 86.7%; p=0.59). | [] | In our study, we divided the patients into two groups, one with a VLPP of lower than 60 cmH2O and the other with a VLPP of higher than 60 cmH2O, and the success rates did not differ significantly between the groups (81.1% versus 86.7%; p=0.59). | true | true | true | true | true | 6,730 |
2 | DISCUSSION | 1 | 23 | [
"B23",
"B24",
"B25",
"B26",
"B27"
] | 20,577,608 | NA|pmid-3822288|pmid-2392816|NA|pmid-11294532 | According to the Ingelman-Sundberg scale, there was no significant difference in the success rate between the symptom Grade II group and the Grade III group postoperatively (83.3% versus 83.9%; p=1.000). | [
"23",
"24",
"25",
"26",
"27"
] | 203 | 39,084 | 0 | false | According to the Ingelman-Sundberg scale, there was no significant difference in the success rate between the symptom Grade II group and the Grade III group postoperatively (83.3% versus 83.9%; p=1.000). | [] | According to the Ingelman-Sundberg scale, there was no significant difference in the success rate between the symptom Grade II group and the Grade III group postoperatively. | true | true | true | true | true | 6,730 |
3 | DISCUSSION | 1 | 14 | [
"B14"
] | 20,577,608 | pmid-11857671 | BFLUTS questionnaire is a self-descriptive urinary symptom measurement tool composed of 4 domains and 34 questions that was developed in 1996 by Abrams et al in the United Kingdom [14]. | [
"14"
] | 185 | 39,085 | 1 | false | BFLUTS questionnaire is a self-descriptive urinary symptom measurement tool composed of 4 domains and 34 questions that was developed in 1996 by Abrams et al in the United Kingdom. | [
"14"
] | BFLUTS questionnaire is a self-descriptive urinary symptom measurement tool composed of 4 domains and 34 questions that was developed in 1996 by Abrams et al in the United Kingdom. | true | true | true | true | true | 6,731 |
3 | DISCUSSION | 1 | 14 | [
"B14"
] | 20,577,608 | pmid-11857671 | The 4 domains of the questionnaire are lower urinary tract symptom severity, sexual function, bothersomeness, and impact and quality of life. | [
"14"
] | 141 | 39,086 | 0 | false | The 4 domains of the questionnaire are lower urinary tract symptom severity, sexual function, bothersomeness, and impact and quality of life. | [] | The 4 domains of the questionnaire are lower urinary tract symptom severity, sexual function, bothersomeness, and impact and quality of life. | true | true | true | true | true | 6,731 |
3 | DISCUSSION | 1 | 14 | [
"B14"
] | 20,577,608 | pmid-11857671 | The scale of answers ranges from 'none' to 'always'. | [
"14"
] | 52 | 39,087 | 0 | false | The scale of answers ranges from 'none' to 'always'. | [] | The scale of answers ranges from 'none' to 'always'. | true | true | true | true | true | 6,731 |
3 | DISCUSSION | 1 | 14 | [
"B14"
] | 20,577,608 | pmid-11857671 | The questionnaire is designed so that the severity of symptoms can be evaluated and the impact of LUTS on daily life can be measured on every question. | [
"14"
] | 151 | 39,088 | 0 | false | The questionnaire is designed so that the severity of symptoms can be evaluated and the impact of LUTS on daily life can be measured on every question. | [] | The questionnaire is designed so that the severity of symptoms can be evaluated and the impact of LUTS on daily life can be measured on every question. | true | true | true | true | true | 6,731 |
3 | DISCUSSION | 1 | 14 | [
"B14"
] | 20,577,608 | pmid-11857671 | This is useful in evaluating the change in urinary symptoms before and after treatment, and the reproducibility and validity are known to be reliable. | [
"14"
] | 150 | 39,089 | 0 | false | This is useful in evaluating the change in urinary symptoms before and after treatment, and the reproducibility and validity are known to be reliable. | [] | This is useful in evaluating the change in urinary symptoms before and after treatment, and the reproducibility and validity are known to be reliable. | true | true | true | true | true | 6,731 |
3 | DISCUSSION | 1 | 14 | [
"B14"
] | 20,577,608 | pmid-11857671 | In our study, we selected some questions from the questionnaire associated with urgency, urgency UI, SUI, incontinence amount, straining, intermittency, feeling of incomplete emptying, and quality of life. | [
"14"
] | 205 | 39,090 | 0 | false | In our study, we selected some questions from the questionnaire associated with urgency, urgency UI, SUI, incontinence amount, straining, intermittency, feeling of incomplete emptying, and quality of life. | [] | In our study, we selected some questions from the questionnaire associated with urgency, urgency UI, SUI, incontinence amount, straining, intermittency, feeling of incomplete emptying, and quality of life. | true | true | true | true | true | 6,731 |
3 | DISCUSSION | 1 | 14 | [
"B14"
] | 20,577,608 | pmid-11857671 | Independent from the BFLUTS items, 2 questions were added concerning global satisfaction and recommendation. | [
"14"
] | 108 | 39,091 | 0 | false | Independent from the BFLUTS items, 2 questions were added concerning global satisfaction and recommendation. | [] | Independent from the BFLUTS items, 2 questions were added concerning global satisfaction and recommendation. | true | true | true | true | true | 6,731 |
4 | DISCUSSION | 1 | 6 | [
"B6",
"B28"
] | 20,577,608 | pmid-10426241|pmid-15217442 | One of the most common complications of TVT is bladder perforation, which is reported to have a rate of occurrence of 2.3% to 10% | [
"6",
"28"
] | 129 | 39,092 | 0 | false | One of the most common complications of TVT is bladder perforation, which is reported to have a rate of occurrence of 2.3% to 10% | [] | One of the most common complications of TVT is bladder perforation, which is reported to have a rate of occurrence of 2.3% to 10% | true | true | false | true | false | 6,732 |
4 | DISCUSSION | 1 | 6 | [
"B6",
"B28"
] | 20,577,608 | pmid-10426241|pmid-15217442 | In our study, 9 patients out of 141 (6.4%) were reported to experience bladder perforation. | [
"6",
"28"
] | 91 | 39,093 | 0 | false | In our study, 9 patients out of 141 were reported to experience bladder perforation. | [
"6.4%"
] | In our study, 9 patients out of 141 were reported to experience bladder perforation. | true | true | true | true | true | 6,732 |
4 | DISCUSSION | 1 | 6 | [
"B6",
"B28"
] | 20,577,608 | pmid-10426241|pmid-15217442 | Our results are comparable with those of previous studies. | [
"6",
"28"
] | 58 | 39,094 | 0 | false | Our results are comparable with those of previous studies. | [] | Our results are comparable with those of previous studies. | true | true | true | true | true | 6,732 |
5 | DISCUSSION | 0 | null | null | 20,577,608 | null | The limitations of this study are, first, that it was a retrospective study, and second, that the BFLUTS questionnaire was used selectively. | null | 140 | 39,095 | 0 | false | null | null | The limitations of this study are, first, that it was a retrospective study, and second, that the BFLUTS questionnaire was used selectively. | true | true | true | true | true | 6,733 |
5 | DISCUSSION | 0 | null | null | 20,577,608 | null | We added subjective questions of our own accord, therefore lowering the validity of the questionnaire. | null | 102 | 39,096 | 0 | false | null | null | We added subjective questions of our own accord, therefore lowering the validity of the questionnaire. | true | true | true | true | true | 6,733 |
5 | DISCUSSION | 0 | null | null | 20,577,608 | null | Third, there was a difference in the follow-up evaluation performed between 1 year and 6 years after the TVT, yet these results were compared and analyzed. | null | 155 | 39,097 | 0 | false | null | null | Third, there was a difference in the follow-up evaluation performed between 1 year and 6 years after the TVT, yet these results were compared and analyzed. | true | true | true | true | true | 6,733 |
5 | DISCUSSION | 0 | null | null | 20,577,608 | null | Fourth, the study was based on the patients' subjective data and satisfaction. | null | 78 | 39,098 | 0 | false | null | null | Fourth, the study was based on the patients' subjective data and satisfaction. | true | true | true | true | true | 6,733 |
5 | DISCUSSION | 0 | null | null | 20,577,608 | null | The severity of symptoms would probably vary from patient to patient; therefore, judgement of cure, improvement, and failure on the basis of these analyses may not always be accurate. | null | 183 | 39,099 | 0 | false | null | null | The severity of symptoms would probably vary from patient to patient; therefore, judgement of cure, improvement, and failure on the basis of these analyses may not always be accurate. | true | true | true | true | true | 6,733 |
5 | DISCUSSION | 0 | null | null | 20,577,608 | null | If objective data such as uroflowmetry, residual urine measurement, and stress test had been collected at the 6-year follow-up, the results would probably have been more significant and reliable. | null | 195 | 39,100 | 0 | false | null | null | If objective data such as uroflowmetry, residual urine measurement, and stress test had been collected at the 6-year follow-up, the results would probably have been more significant and reliable. | true | true | true | true | true | 6,733 |
5 | DISCUSSION | 0 | null | null | 20,577,608 | null | Finally, this study was dependent on a questionnaire conducted by telephone interview; therefore, this study is vulnerable to selection bias. | null | 141 | 39,101 | 0 | false | null | null | Finally, this study was dependent on a questionnaire conducted by telephone interview; therefore, this study is vulnerable to selection bias. | true | true | true | true | true | 6,733 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 19,321,500 | pmid-3181145|pmid-7826014|pmid-15463739|pmid-15811531|pmid-14555465|pmid-17765983|pmid-1349605|pmid-17041189 | Leishmaniasis is caused by trypanosomatid parasites that cycle between invertebrate vectors and vertebrate hosts, transforming between the promastigote and amastigote life forms, respectively. | [
"1",
"2",
"3",
"4",
"5",
"6",
"7"
] | 192 | 39,102 | 0 | false | Leishmaniasis is caused by trypanosomatid parasites that cycle between invertebrate vectors and vertebrate hosts, transforming between the promastigote and amastigote life forms, respectively. | [] | Leishmaniasis is caused by trypanosomatid parasites that cycle between invertebrate vectors and vertebrate hosts, transforming between the promastigote and amastigote life forms, respectively. | true | true | true | true | true | 6,734 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 19,321,500 | pmid-3181145|pmid-7826014|pmid-15463739|pmid-15811531|pmid-14555465|pmid-17765983|pmid-1349605|pmid-17041189 | Environmental conditions, such as temperature and pH switches, were shown to induce a stage-specific pattern of gene expression (1,2), which in some species is sufficient to produce the axenic form (amastigotes) observed in mammalian cells (3,4). | [
"1",
"2",
"3",
"4",
"5",
"6",
"7"
] | 246 | 39,103 | 0 | false | Environmental conditions, such as temperature and pH switches, were shown to induce a stage-specific pattern of gene expression, which in some species is sufficient to produce the axenic form (amastigotes) observed in mammalian cells. | [
"1,2",
"3,4"
] | Environmental conditions, such as temperature and pH switches, were shown to induce a stage-specific pattern of gene expression, which in some species is sufficient to produce the axenic form (amastigotes) observed in mammalian cells. | true | true | true | true | true | 6,734 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 19,321,500 | pmid-3181145|pmid-7826014|pmid-15463739|pmid-15811531|pmid-14555465|pmid-17765983|pmid-1349605|pmid-17041189 | Trypanosomatids are ancient eukaryotes that diverged early in evolution and therefore display a variety of unique molecular features. | [
"1",
"2",
"3",
"4",
"5",
"6",
"7"
] | 133 | 39,104 | 0 | false | Trypanosomatids are ancient eukaryotes that diverged early in evolution and therefore display a variety of unique molecular features. | [] | Trypanosomatids are ancient eukaryotes that diverged early in evolution and therefore display a variety of unique molecular features. | true | true | true | true | true | 6,734 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 19,321,500 | pmid-3181145|pmid-7826014|pmid-15463739|pmid-15811531|pmid-14555465|pmid-17765983|pmid-1349605|pmid-17041189 | Transcription of protein-coding genes is polycistronic and the resulting pre-mRNAs are processed by trans-splicing and polyadenylation (5,6). | [
"1",
"2",
"3",
"4",
"5",
"6",
"7"
] | 141 | 39,105 | 0 | false | Transcription of protein-coding genes is polycistronic and the resulting pre-mRNAs are processed by trans-splicing and polyadenylation. | [
"5,6"
] | Transcription of protein-coding genes is polycistronic and the resulting pre-mRNAs are processed by trans-splicing and polyadenylation. | true | true | true | true | true | 6,734 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 19,321,500 | pmid-3181145|pmid-7826014|pmid-15463739|pmid-15811531|pmid-14555465|pmid-17765983|pmid-1349605|pmid-17041189 | During trans-splicing, a capped 39-nt exon of the spliced leader RNA is joined to the 5′-end of all transcripts. | [
"1",
"2",
"3",
"4",
"5",
"6",
"7"
] | 112 | 39,106 | 0 | false | During trans-splicing, a capped 39-nt exon of the spliced leader RNA is joined to the 5′-end of all transcripts. | [] | During trans-splicing, a capped 39-nt exon of the spliced leader RNA is joined to the 5′-end of all transcripts. | true | true | true | true | true | 6,734 |
0 | INTRODUCTION | 1 | 7 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B6",
"B7"
] | 19,321,500 | pmid-3181145|pmid-7826014|pmid-15463739|pmid-15811531|pmid-14555465|pmid-17765983|pmid-1349605|pmid-17041189 | The 5′-cap of trypanosomatids consists of a highly modified structure, which in addition to the m7GTP cap found at the 5′-end of most eukaryotic mRNAs, contains 2′-O-methylations on the ribose moieties of the first four transcribed nucleotides and unusual base-methylations on the first adenine and fourth uridine (m7Gpp... | [
"1",
"2",
"3",
"4",
"5",
"6",
"7"
] | 392 | 39,107 | 1 | false | The 5′-cap of trypanosomatids consists of a highly modified structure, which in addition to the m7GTP cap found at the 5′-end of most eukaryotic mRNAs, contains 2′-O-methylations on the ribose moieties of the first four transcribed nucleotides and unusual base-methylations on the first adenine and fourth uridine ; this... | [
"m7Gpppm36,6,2′Apm2′Apm2′Cpm23,2′U",
"7"
] | The 5′-cap of trypanosomatids consists of a highly modified structure, which in addition to the m7GTP cap found at the 5′-end of most eukaryotic mRNAs, contains 2′-O-methylations on the ribose moieties of the first four transcribed nucleotides and unusual base-methylations on the first adenine and fourth uridine ; this... | true | true | true | true | true | 6,734 |
1 | INTRODUCTION | 1 | 8 | [
"B8",
"B9",
"B10",
"B11",
"B12",
"B13",
"B9",
"B14"
] | 19,321,500 | pmid-9019810|pmid-11909525|pmid-7665619|pmid-11022043|pmid-9702200|pmid-10364159|pmid-11909525|pmid-16194295|pmid-18713834|pmid-17041189 | Cap-dependent translation is a common mechanism in higher eukaryotes, which requires several factors. | [
"8",
"9",
"10",
"11",
"12",
"13",
"9",
"14"
] | 101 | 39,108 | 0 | false | Cap-dependent translation is a common mechanism in higher eukaryotes, which requires several factors. | [] | Cap-dependent translation is a common mechanism in higher eukaryotes, which requires several factors. | true | true | true | true | true | 6,735 |
1 | INTRODUCTION | 1 | 8 | [
"B8",
"B9",
"B10",
"B11",
"B12",
"B13",
"B9",
"B14"
] | 19,321,500 | pmid-9019810|pmid-11909525|pmid-7665619|pmid-11022043|pmid-9702200|pmid-10364159|pmid-11909525|pmid-16194295|pmid-18713834|pmid-17041189 | The cap-binding complex, eIF4F, consists of three subunits, with eIF4G serving as a scaffold protein for the whole complex (8,9). | [
"8",
"9",
"10",
"11",
"12",
"13",
"9",
"14"
] | 129 | 39,109 | 0 | false | The cap-binding complex, eIF4F, consists of three subunits, with eIF4G serving as a scaffold protein for the whole complex. | [
"8,9"
] | The cap-binding complex, eIF4F, consists of three subunits, with eIF4G serving as a scaffold protein for the whole complex. | true | true | true | true | true | 6,735 |
1 | INTRODUCTION | 1 | 8 | [
"B8",
"B9",
"B10",
"B11",
"B12",
"B13",
"B9",
"B14"
] | 19,321,500 | pmid-9019810|pmid-11909525|pmid-7665619|pmid-11022043|pmid-9702200|pmid-10364159|pmid-11909525|pmid-16194295|pmid-18713834|pmid-17041189 | eIF4G holds the cap-binding protein, eIF4E, and the ATP-dependent RNA helicase, eIF4A. | [
"8",
"9",
"10",
"11",
"12",
"13",
"9",
"14"
] | 86 | 39,110 | 0 | false | eIF4G holds the cap-binding protein, eIF4E, and the ATP-dependent RNA helicase, eIF4A. | [] | eIF4G holds the cap-binding protein, eIF4E, and the ATP-dependent RNA helicase, eIF4A. | false | true | true | true | false | 6,735 |
1 | INTRODUCTION | 1 | 8 | [
"B8",
"B9",
"B10",
"B11",
"B12",
"B13",
"B9",
"B14"
] | 19,321,500 | pmid-9019810|pmid-11909525|pmid-7665619|pmid-11022043|pmid-9702200|pmid-10364159|pmid-11909525|pmid-16194295|pmid-18713834|pmid-17041189 | eIF4G also associates with eIF3 (10,11), a multisubunit factor that bridges the cap-binding complex and the small ribosomal subunit, as well as with the poly(A)-binding protein (PABP), which is found on the 3′-end of most eukaryotic mRNAs. | [
"8",
"9",
"10",
"11",
"12",
"13",
"9",
"14"
] | 239 | 39,111 | 0 | false | eIF4G also associates with eIF3, a multisubunit factor that bridges the cap-binding complex and the small ribosomal subunit, as well as with the poly(A)-binding protein (PABP), which is found on the 3′-end of most eukaryotic mRNAs. | [
"10,11"
] | eIF4G also associates with eIF3, a multisubunit factor that bridges the cap-binding complex and the small ribosomal subunit, as well as with the poly(A)-binding protein (PABP), which is found on the 3′-end of most eukaryotic mRNAs. | false | true | true | true | false | 6,735 |
1 | INTRODUCTION | 1 | 8 | [
"B8",
"B9",
"B10",
"B11",
"B12",
"B13",
"B9",
"B14"
] | 19,321,500 | pmid-9019810|pmid-11909525|pmid-7665619|pmid-11022043|pmid-9702200|pmid-10364159|pmid-11909525|pmid-16194295|pmid-18713834|pmid-17041189 | These latter interactions allow the mRNA circularization, which is assumed to stimulate translation initiation (12,13). | [
"8",
"9",
"10",
"11",
"12",
"13",
"9",
"14"
] | 119 | 39,112 | 0 | false | These latter interactions allow the mRNA circularization, which is assumed to stimulate translation initiation. | [
"12,13"
] | These latter interactions allow the mRNA circularization, which is assumed to stimulate translation initiation. | true | true | true | true | true | 6,735 |
1 | INTRODUCTION | 1 | 8 | [
"B8",
"B9",
"B10",
"B11",
"B12",
"B13",
"B9",
"B14"
] | 19,321,500 | pmid-9019810|pmid-11909525|pmid-7665619|pmid-11022043|pmid-9702200|pmid-10364159|pmid-11909525|pmid-16194295|pmid-18713834|pmid-17041189 | Assembly of the translation initiation complex on the 5′-mRNA cap structure (m7GTP) is rate-limiting and is therefore subject to strict regulation (9,14). | [
"8",
"9",
"10",
"11",
"12",
"13",
"9",
"14"
] | 154 | 39,113 | 0 | false | Assembly of the translation initiation complex on the 5′-mRNA cap structure (m7GTP) is rate-limiting and is therefore subject to strict regulation. | [
"9,14"
] | Assembly of the translation initiation complex on the 5′-mRNA cap structure (m7GTP) is rate-limiting and is therefore subject to strict regulation. | true | true | true | true | true | 6,735 |
2 | INTRODUCTION | 1 | 10 | [
"B10",
"B15",
"B16",
"B17",
"B18",
"B19",
"B20",
"B21",
"B22",
"B23",
"B24",
"B25"
] | 19,321,500 | pmid-7665619|pmid-9857202|pmid-9003792|pmid-10394359|pmid-14675538|pmid-9372926|pmid-11172724|pmid-16698552|pmid-16156639|pmid-11943866|pmid-18451872|pmid-18450493 | The human eIF4G (1600 amino acids) possesses three domains that are defined by viral protease cleavage patterns (10). | [
"10",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23",
"24",
"25"
] | 117 | 39,114 | 1 | false | The human eIF4G possesses three domains that are defined by viral protease cleavage patterns. | [
"1600 amino acids",
"10"
] | The human eIF4G possesses three domains that are defined by viral protease cleavage patterns. | true | true | true | true | true | 6,736 |
2 | INTRODUCTION | 1 | 10 | [
"B10",
"B15",
"B16",
"B17",
"B18",
"B19",
"B20",
"B21",
"B22",
"B23",
"B24",
"B25"
] | 19,321,500 | pmid-7665619|pmid-9857202|pmid-9003792|pmid-10394359|pmid-14675538|pmid-9372926|pmid-11172724|pmid-16698552|pmid-16156639|pmid-11943866|pmid-18451872|pmid-18450493 | The N-terminal segment includes eIF4E and PABP binding sites (15,16). | [
"10",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23",
"24",
"25"
] | 69 | 39,115 | 0 | false | The N-terminal segment includes eIF4E and PABP binding sites. | [
"15,16"
] | The N-terminal segment includes eIF4E and PABP binding sites. | true | true | true | true | true | 6,736 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.